Stay updated on GEMINI 2 Tolebrutinib in RMS Clinical Trial
Sign up to get notified when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.

Latest updates to the GEMINI 2 Tolebrutinib in RMS Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now signals that recruitment is closed to new participants and adds How to Read a Study Record, Common Questions, and How to Join a Study for user guidance. The Interventions header formatting changed from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision indicator was updated to Revision: v3.6.0.SummaryDifference0.2%

- Check21 days agoChange DetectedA new revision tag 'Revision: v3.5.5' has been added, and the previous 'Revision: v3.5.4' has been removed. This signals a refreshed release of the page content.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a software/build update for the page. This change does not alter the study content or public-facing information.SummaryDifference0.0%

- Check64 days agoChange DetectedThe study’s location listing for “Gūrgaon, India” was normalized to “Gurgaon, India” for two entries, likely correcting diacritic formatting. The page also reflects an update to the site/page “Revision” version.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check93 days agoChange DetectedAdded two location entries: Gūrgaon, India, 122001 and Gūrgaon, India, 122002. Removed Gurgaon, India, 122001 and Gurgaon, India, 122002.SummaryDifference0.0%

Stay in the know with updates to GEMINI 2 Tolebrutinib in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.